Trade PHAR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pharming Group N.V. ADS, each representing 10 (PHAR) is trading at US$9.79, up 2.73% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$838.72M. Over the past 52 weeks, PHAR has traded between US$9.44 and US$21.34. On Syfe you can trade PHAR with $0 commission and add it to your watchlist.
| Previous close | US$9.53 |
|---|---|
| Market cap | US$838.72M |
| P/E ratio | 45.32 |
| 52-week range | US$9.44 – US$21.34 |
| Volume | 3.33K |
| Exchange | US |
Pharming Group N.V. ADS, each representing 10
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Year: 2020
Pharming Gets FDA Approval for Joenja to Treat APDS in Children Aged 4-11
Sep 11, 5:16 PM · MT Newswires
Pharming Group N.V. ADS, each representing 10 (PHAR) stock is trading at US$9.79, +2.73% from the previous close of US$9.53.
The market cap for Pharming Group N.V. ADS, each representing 10 (PHAR) stock is approximately US$838.72M.
The price-to-earnings ratio for Pharming Group N.V. ADS, each representing 10 (PHAR) is 45.32, based on the latest reported earnings.
The 52-week high for Pharming Group N.V. ADS, each representing 10 (PHAR) stock is US$21.34.
The 52-week low for Pharming Group N.V. ADS, each representing 10 (PHAR) stock is US$9.44.
Pharming Group N.V. ADS, each representing 10 (PHAR) does not currently pay a dividend.
Stay on top of PHAR
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
